Acceptable 0 10 0 10 O
maintenance 11 22 11 22 O
agents 23 29 23 29 O
include 30 37 30 37 O
azathioprine 38 50 38 50 B-treatment
, 50 51 50 51 O
leflunomide 52 63 52 63 B-treatment
, 63 64 63 64 O
6 65 66 65 66 B-treatment
- 66 67 66 67 I-treatment
mercaptopurine 67 81 67 81 I-treatment
, 81 82 81 82 O
methotrexate 83 95 83 95 B-treatment
, 95 96 95 96 O
mycophenolate 97 110 97 110 B-treatment
mofetil 111 118 111 118 I-treatment
, 118 119 118 119 O
mycophenolate 120 133 120 133 B-treatment
sodium 134 140 134 140 I-treatment
, 140 141 140 141 O
or 142 144 142 144 O
rituximab 145 154 145 154 B-treatment
. 154 155 154 155 O
Patients 156 164 156 164 O
may 165 168 165 168 O
be 169 171 169 171 O
on 172 174 172 174 O
trimethoprim 175 187 175 187 B-treatment
/ 187 188 187 188 I-treatment
sulfamethoxazole 188 204 188 204 I-treatment
( 205 206 205 206 I-treatment
TMP 206 209 206 209 I-treatment
/ 209 210 209 210 I-treatment
SMX 210 213 210 213 I-treatment
) 213 214 213 214 I-treatment
for 215 218 215 218 O
use 219 222 219 222 O
as 223 225 223 225 O
either 226 232 226 232 O
a 233 234 233 234 O
maintenance 235 246 235 246 O
agent 247 252 247 252 O
or 253 255 253 255 O
for 256 259 256 259 O
prophylaxis 260 271 260 271 B-treatment
for 272 275 272 275 O
infection 276 285 276 285 O
. 285 286 285 286 O
TMP 287 290 287 290 O
/ 290 291 290 291 O
SMX 291 294 291 294 O
may 295 298 295 298 O
be 299 301 299 301 O
used 302 306 302 306 O
in 307 309 307 309 O
combination 310 321 310 321 O
with 322 326 322 326 O
other 327 332 327 332 O
drugs 333 338 333 338 O

Active 0 6 339 345 B-chronic_disease
disease 7 14 346 353 I-chronic_disease
within 15 21 354 360 O
the 22 25 361 364 O
prior 26 31 365 370 B-upper_bound
12 32 34 371 373 I-upper_bound
months 35 41 374 380 I-upper_bound
( 42 43 381 382 O
initial 43 50 382 389 O
presentation 51 63 390 402 O
or 64 66 403 405 O
relapse 67 74 406 413 O
) 74 75 413 414 O
that 76 80 415 419 O
at 81 83 420 422 O
time 84 88 423 427 O
of 89 91 428 430 O
active 92 98 431 437 O
disease 99 106 438 445 O
required 107 115 446 454 O
treatment 116 125 455 464 O
with 126 130 465 469 O
prednisone 131 141 470 480 B-treatment
> 142 143 481 482 O
20 143 145 482 484 B-lower_bound
mg 146 148 485 487 I-lower_bound
/ 148 149 487 488 I-lower_bound
day 149 152 488 491 I-lower_bound

Active 0 6 492 498 O
urinary 7 14 499 506 O
sediment 15 23 507 515 O
, 23 24 515 516 O
defined 25 32 517 524 O
as 33 35 525 527 O
microscopic 36 47 528 539 B-chronic_disease
hematuria 48 57 540 549 I-chronic_disease
( 58 59 550 551 O
> 59 60 551 552 O
5 60 61 552 553 B-lower_bound
red 62 65 554 557 O
blood 66 71 558 563 O
cells 72 77 564 569 O
per 78 81 570 573 O
high 82 86 574 578 O
power 87 92 579 584 O
field 93 98 585 590 O
) 98 99 590 591 O
or 100 102 592 594 O
red 103 106 595 598 O
blood 107 112 599 604 O
cell 113 117 605 609 O
casts 118 123 610 615 O

Comorbid 0 8 616 624 O
condition 9 18 625 634 O
that 19 23 635 639 O
has 24 27 640 643 O
moderate 28 36 644 652 O
likelihood 37 47 653 663 O
of 48 50 664 666 O
requiring 51 60 667 676 O
a 61 62 677 678 O
course 63 69 679 685 O
of 70 72 686 688 O
prednisone 73 83 689 699 B-treatment
within 84 90 700 706 O
one 91 94 707 710 B-upper_bound
year 95 99 711 715 I-upper_bound
of 100 102 716 718 O
enrollment 103 113 719 729 O
( 114 115 730 731 O
e.g. 115 119 731 735 O
chronic 120 127 736 743 B-chronic_disease
obstructive 128 139 744 755 I-chronic_disease
pulmonary 140 149 756 765 I-chronic_disease
disease 150 157 766 773 I-chronic_disease
( 158 159 774 775 I-chronic_disease
COPD 159 163 775 779 I-chronic_disease
) 163 164 779 780 I-chronic_disease
, 164 165 780 781 O
asthma 166 172 782 788 B-chronic_disease
, 172 173 788 789 O
adrenal 174 181 790 797 B-chronic_disease
insufficiency 182 195 798 811 I-chronic_disease
) 195 196 811 812 O

Established 0 11 813 824 O
diagnosis 12 21 825 834 O
of 22 24 835 837 O
granulomatosis 25 39 838 852 B-chronic_disease
with 40 44 853 857 I-chronic_disease
polyangiitis 45 57 858 870 I-chronic_disease
( 58 59 871 872 I-chronic_disease
GPA 59 62 872 875 I-chronic_disease
) 62 63 875 876 I-chronic_disease
where 64 69 877 882 O
patients 70 78 883 891 O
will 79 83 892 896 O
need 84 88 897 901 O
to 89 91 902 904 O
meet 92 96 905 909 O
at 97 99 910 912 O
least 100 105 913 918 O
2 106 107 919 920 B-lower_bound
of 108 110 921 923 O
the 111 114 924 927 O
5 115 116 928 929 B-upper_bound
for 117 120 930 933 O
the 121 124 934 937 O
classification 125 139 938 952 O
of 140 142 953 955 O
GPA 143 146 956 959 O

Granulomatosis 0 14 960 974 B-chronic_disease
inflammation 15 27 975 987 I-chronic_disease
on 28 30 988 990 O
biopsy 31 37 991 997 O
, 37 38 997 998 O
defined 39 46 999 1006 O
as 47 49 1007 1009 O
histologic 50 60 1010 1020 O
changes 61 68 1021 1028 O
showing 69 76 1029 1036 O
granulomatous 77 90 1037 1050 B-chronic_disease
inflammation 91 103 1051 1063 I-chronic_disease
within 104 110 1064 1070 O
the 111 114 1071 1074 O
wall 115 119 1075 1079 O
of 120 122 1080 1082 O
an 123 125 1083 1085 O
artery 126 132 1086 1092 O
or 133 135 1093 1095 O
in 136 138 1096 1098 O
the 139 142 1099 1102 O
perivascular 143 155 1103 1115 O
or 156 158 1116 1118 O
extravascular 159 172 1119 1132 O
area 173 177 1133 1137 O

Nasal 0 5 1138 1143 B-chronic_disease
or 6 8 1144 1146 I-chronic_disease
oral 9 13 1147 1151 I-chronic_disease
inflammation 14 26 1152 1164 I-chronic_disease
, 26 27 1164 1165 O
defined 28 35 1166 1173 O
as 36 38 1174 1176 O
the 39 42 1177 1180 O
development 43 54 1181 1192 O
of 55 57 1193 1195 O
painful 58 65 1196 1203 O
or 66 68 1204 1206 O
painless 69 77 1207 1215 O
oral 78 82 1216 1220 B-chronic_disease
ulcers 83 89 1221 1227 I-chronic_disease
or 90 92 1228 1230 O
purulent 93 101 1231 1239 O
or 102 104 1240 1242 O
bloody 105 111 1243 1249 O
nasal 112 117 1250 1255 O
discharge 118 127 1256 1265 O

Participant 0 11 1266 1277 O
age 12 15 1278 1281 B-age
of 16 18 1282 1284 O
18 19 21 1285 1287 B-lower_bound
years 22 27 1288 1293 I-lower_bound
or 28 30 1294 1296 O
greater 31 38 1297 1304 O

Positive 0 8 1305 1313 O
anti 9 13 1314 1318 B-chronic_disease
- 13 14 1318 1319 I-chronic_disease
neutrophil 14 24 1319 1329 I-chronic_disease
cytoplasmic 25 36 1330 1341 I-chronic_disease
antibody 37 45 1342 1350 I-chronic_disease
( 46 47 1351 1352 I-chronic_disease
ANCA 47 51 1352 1356 I-chronic_disease
) 51 52 1356 1357 I-chronic_disease
test 53 57 1358 1362 O
specific 58 66 1363 1371 O
for 67 70 1372 1375 O
proteinase-3 71 83 1376 1388 O
measures 84 92 1389 1397 O
by 93 95 1398 1400 O
enzyme 96 102 1401 1407 B-treatment
- 102 103 1407 1408 I-treatment
linked 103 109 1408 1414 I-treatment
immunoassay 110 121 1415 1426 I-treatment

Prednisone 0 10 1427 1437 B-treatment
dose 11 15 1438 1442 O
at 16 18 1443 1445 O
time 19 23 1446 1450 O
of 24 26 1451 1453 O
enrollment 27 37 1454 1464 O
of 38 40 1465 1467 O
≥ 41 42 1468 1469 O
5 43 44 1470 1471 B-lower_bound
mg 45 47 1472 1474 I-lower_bound
/ 47 48 1474 1475 I-lower_bound
day 48 51 1475 1478 I-lower_bound
and 52 55 1479 1482 O
≤ 56 57 1483 1484 O
20 58 60 1485 1487 B-upper_bound
mg 61 63 1488 1490 I-upper_bound
/ 63 64 1490 1491 I-upper_bound
day 64 67 1491 1494 I-upper_bound

